Effect of Agonist on reproductio

Phase 3

• Conditions: N97; N98; Diseases of the genitourinary system.; Female infertility; Complications associated with artificial fertilization

• Registration Number: IRCT20160815029374N4
• Lead Sponsor: Vice chancellor of Mazandaran University of Medical Science.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 May 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Infertile women aged 20 to 45 years
Normal hysterosalpingography
AMH levels < 1.5 ng/ml
Antral follicular counts (AFC) < 7 in both ovaries
Prior less than three failed in vitro fertilization cycles

Exclusion Criteria

Normal ovarian response in ovulatory cycles or in vitro fertilization cycles

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical pregnancy rate. Timepoint: Forth weeks after embryo transfer. Method of measurement: Utrasound.

Secondary Outcome Measures

Name	Time	Method
Oocyte recovery rate. Timepoint: 48 hours after HCG injection. Method of measurement: Observation by microscopy.;Embryo rate. Timepoint: three days after oocyte recovery. Method of measurement: Observation by microscopy.;Miscarriage rate. Timepoint: Till twenty weeks after embryo transfer. Method of measurement: Ultrasound.;Oocyte quality. Timepoint: On oocyte recovery rate. Method of measurement: Observation by microscopy.